Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis



Large-scale randomized trials have established that dual antiplatelet therapy with aspirin and clopidogrel reduces major cardiovascular events in fibrinolytic-treated ST-segment elevation myocardial infarction (STEMI) patients.

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our